PUBLIC COMPANY
saveCHEPLAPHARM
USupdated 1mo ago
community read0 votes
pipeline
0
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(0)
no pipeline products on record
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →🐶 Hiring Signal
News
- GSK pens $1.3B Hutchmed deal for early-stage KRAS-EGFR cancer assetGSK is handing over $110 million upfront to Hutchmed in a deal worth up to $1.295 billion to get its hands on a first-in-class oncology candidate.fiercebiotech · 19d ago
comments(0)
5-min edit window · permanent after that